Hester Biosciences Limited (BOM:524669)
India flag India · Delayed Price · Currency is INR
2,450.55
+13.95 (0.57%)
At close: Aug 6, 2026

Hester Biosciences Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
3,2573,3263,1113,0452,6612,350
Other Revenue
15.2215.2213.7266.48121.14116.41
3,2733,3413,1253,1122,7822,466
Revenue Growth
4.12%6.93%0.41%11.86%12.80%13.30%
Cost of Revenue
822.78876.61928.37997.28824.81678.19
Gross Profit
2,4502,4652,1962,1151,9571,788
Selling, General & Admin
723.16727.14728.49752.69675.39516.02
Other Operating Expenses
762772.43843.64758.94654.62536.16
Operating Expenses
1,7861,7721,7401,6831,5371,238
Operating Income
664692.99456.22431.29420.28550.43
Interest Expense
-86.86-74.16-83.4-91.19-51.49-25.76
Interest & Investment Income
15.7915.7920.3719.0721.7319.03
Earnings From Equity Investments
73.6163.734146.0944.094.23
Currency Exchange Gain (Loss)
19.1719.17-33.62-94.68-29.92-4.59
Other Non Operating Income (Expenses)
-12.82-6.09-4.86-3.1-3.31-9.57
EBT Excluding Unusual Items
672.89711.43395.71307.48401.38533.77
Gain (Loss) on Sale of Investments
17.5717.57----
Gain (Loss) on Sale of Assets
---0.280.161.25
Other Unusual Items
882.8529.36-11.77--
Pretax Income
1,573758.36395.71319.53401.54535.02
Income Tax Expense
204.11183.52107.45107.87121.19140.18
Earnings From Continuing Operations
1,369574.84288.26211.66280.35394.84
Minority Interest in Earnings
-7.42-18.45-13.38-22.77-14.08-1.64
Net Income
1,362556.39274.88188.89266.27393.2
Net Income to Common
1,362556.39274.88188.89266.27393.2
Net Income Growth
262.23%102.41%45.52%-29.06%-32.28%14.20%
Shares Outstanding (Basic)
999999
Shares Outstanding (Diluted)
999999
Shares Change
-1.28%-----
EPS (Basic)
158.0365.4032.3122.2031.3046.22
EPS (Diluted)
158.0365.4032.3122.2031.3046.22
EPS Growth
266.92%102.41%45.52%-29.06%-32.28%14.20%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-463.13439.2237.86-541.66-869.98
Free Cash Flow Per Share
-54.4451.6327.96-63.67-102.27
Dividend Per Share
-11.0007.0006.0008.00010.000
Dividend Growth
-57.14%16.67%-25.00%-20.00%0%
Gross Margin
74.86%73.76%70.29%67.95%70.35%72.50%
Operating Margin
20.29%20.74%14.60%13.86%15.11%22.32%
Profit Margin
41.61%16.65%8.80%6.07%9.57%15.94%
Free Cash Flow Margin
-13.86%14.06%7.64%-19.47%-35.27%
EBITDA
792.08816.73562.6599.98624.22712.92
EBITDA Margin
24.20%24.44%18.00%19.28%22.44%28.90%
D&A For EBITDA
128.08123.74106.38168.69203.94162.49
EBIT
664692.99456.22431.29420.28550.43
EBIT Margin
20.29%20.74%14.60%13.86%15.11%22.32%
Effective Tax Rate
12.97%24.20%27.15%33.76%30.18%26.20%
Revenue as Reported
3,3473,4233,1503,1522,8122,487
Advertising Expenses
-70.4877.7388.0699.7449.63